tiprankstipranks
Advertisement
Advertisement

NGNE Stock Latest News

Short Report: Ondas bearish bets at record highs
The FlyShort Report: Ondas bearish bets at record highs
15d ago
NGNE
NTST
Patrick Dolezal Raises Price Target to $65 and Reiterates Buy on NGN-401’s Differentiated Profile and Strong Embolden Study Design
PremiumRatings
Patrick Dolezal Raises Price Target to $65 and Reiterates Buy on NGN-401’s Differentiated Profile and Strong Embolden Study Design
19d ago
NGNE
Neurogene bolsters cash runway with equity offering
PremiumCompany Announcements
Neurogene bolsters cash runway with equity offering
24d ago
8K
NGNE
Neurogene prices 3.5M shares at $30.00 in public offering
PremiumThe Fly
Neurogene prices 3.5M shares at $30.00 in public offering
25d ago
NGNE
Neurogene 75M Spot Secondary; re-offered at $30.00
PremiumThe Fly
Neurogene 75M Spot Secondary; re-offered at $30.00
25d ago
NGNE
Neurogene announces common stock offering, no amount given
PremiumThe FlyNeurogene announces common stock offering, no amount given
25d ago
NGNE
Analyst Reiterates Buy on Neurogene as Rett Gene Therapy Data Strengthens Case; $180 Price Target Maintained
Premium
Ratings
Analyst Reiterates Buy on Neurogene as Rett Gene Therapy Data Strengthens Case; $180 Price Target Maintained
26d ago
NGNE
Kapoor Reiterates Buy on NGNE, Citing Strong NGN-401 Data and Maintains $70 Price Target
Premium
Ratings
Kapoor Reiterates Buy on NGNE, Citing Strong NGN-401 Data and Maintains $70 Price Target
26d ago
NGNE
Sami Corwin Reiterates Buy on Neurogene as NGN-401’s Strong Long-Term Rett Data De-Risk Embolden Trial and Support Favorable Risk‑Reward
PremiumRatings
Sami Corwin Reiterates Buy on Neurogene as NGN-401’s Strong Long-Term Rett Data De-Risk Embolden Trial and Support Favorable Risk‑Reward
27d ago
NGNE
Neurogene reports promising long-term NGN-401 Rett data
PremiumCompany Announcements
Neurogene reports promising long-term NGN-401 Rett data
27d ago
8K
NGNE
Neurogene announces data from Phase 1/2 trial of NGN-401
PremiumThe Fly
Neurogene announces data from Phase 1/2 trial of NGN-401
27d ago
NGNE
Neurogene Earns Buy Rating as NGN-401 Shows Superior Efficacy in Rett Syndrome; $60 Price Target Reaffirmed
PremiumRatings
Neurogene Earns Buy Rating as NGN-401 Shows Superior Efficacy in Rett Syndrome; $60 Price Target Reaffirmed
1M ago
NGNE
Neurogene: Buy Rating Reiterated as NGN-401 Rett Program Advances Toward BLA with $70 Price Target Unchanged
PremiumRatingsNeurogene: Buy Rating Reiterated as NGN-401 Rett Program Advances Toward BLA with $70 Price Target Unchanged
2M ago
NGNE
Neurogene: EMBOLDEN Trial Milestone, Competitive Lead Support Reiterated Buy and Unchanged $60 Price Target
Premium
Ratings
Neurogene: EMBOLDEN Trial Milestone, Competitive Lead Support Reiterated Buy and Unchanged $60 Price Target
2M ago
NGNE
Neurogene Completes Dosing in Embolden Rett Trial
Premium
Company Announcements
Neurogene Completes Dosing in Embolden Rett Trial
2M ago
8K
NGNE
Neurogene completes dosing in Embolden trial of NGN-401
PremiumThe Fly
Neurogene completes dosing in Embolden trial of NGN-401
2M ago
NGNE
Neurogene Stockholders Vote on Directors and Executive Pay
PremiumCompany Announcements
Neurogene Stockholders Vote on Directors and Executive Pay
2M ago
8K
NGNE
Neurogene initiated with a Buy at Rodman & Renshaw
PremiumThe Fly
Neurogene initiated with a Buy at Rodman & Renshaw
2M ago
NGNE
Analyst Reiterates Buy on Neurogene, Maintains $70 Price Target on Promising NGN-401 Profile and Solid Cash Runway
PremiumRatings
Analyst Reiterates Buy on Neurogene, Maintains $70 Price Target on Promising NGN-401 Profile and Solid Cash Runway
2M ago
NGNE
Neurogene Maintains Buy Rating as Embolden Trial Progresses and Cash Runway Supports Unchanged $180 Price Target
PremiumRatingsNeurogene Maintains Buy Rating as Embolden Trial Progresses and Cash Runway Supports Unchanged $180 Price Target
2M ago
NGNE
Neurogene reports Q1 EPS ($1.39), consensus ($1.27)
Premium
The Fly
Neurogene reports Q1 EPS ($1.39), consensus ($1.27)
2M ago
NGNE
Is NGNE a Buy, Before Earnings?
Premium
Pre-Earnings
Is NGNE a Buy, Before Earnings?
3M ago
NGNE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >